- Home
- Equipment
- netherlands
- bioptic
Refine by
Bioptic Equipment Supplied In Netherlands
6 equipment items found
Manufactured by:ENDRA Life Sciences Inc. based inAnn Arbor, MICHIGAN (USA)
Thermo-Acoustic Enhanced UltraSound (TAEUS) combines radio frequency and ultrasound waves to measure fat in the liver in a groundbreaking way. ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Soteria Medical BV’s goal is to improve MR-guided biopsies (MRgBx) of the prostate. Soteria has developed a robot for MR-guided interventions - based on a novel, patented motor principle. The main objectives are to improve accuracy, duration, cost and reliability of existing procedures. We are enabling the Physician to perform a targeted prostate biopsy – using the best possible ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
Designed for radio-guided surgical procedures, the sterile, disposable SENSEI® probe quickly expands the field of view and enables the localization of radioactive hotpots in multiple ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
Using next-generation miniaturized sensor technology, the SENSEI probe measures just over 40mm in length, enabling unprecedented intracavity maneuverability and anatomic access for surgical ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...